Companies that have submitted a pre-market device submission to FDA should be hearing from the agency more often during the review process under the new user fee program, the agency says. A new draft guidance from the device center describes more precisely when sponsors should expect reviewers to drop them a line.
The document, on “Types of Communications During the Review of Medical Device Submissions,” was issued March 4. It’s an update,...